Olema Pharmaceuticals (OLMA) PT Raised to $16 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts OLMA Hot Sheet
Price: $7.54 --0%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 20 | Down: 37 | New: 6
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on Olema Pharmaceuticals (NASDAQ: OLMA) to $16.00 (from $14.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Corpay (CPAY) PT Raised to $525 at Keefe, Bruyette & Woods After 'Another Strong Quarter'
- AppLovin Corp (APP) PT Raised to $355 at Piper Sandler
- Climb Bio (CLYM) PT Raised to $27 at Wedbush, 'remains on our Wedbush Best Ideas List'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
